Filing Details

Accession Number:
0001079973-12-000499
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-07-02 15:41:09
Reporting Period:
2012-06-29
Filing Date:
2012-07-02
Accepted Time:
2012-07-02 14:41:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1167419 Aspenbio Pharma Inc. APPY In Vitro & In Vivo Diagnostic Substances (2835) 841553387
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1008071 Gregory Pusey C/O Aspenbio Pharma, Inc.
1585 S. Perry Street
Castle Rock CO 80104
Vice President Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-06-29 2,000 $1.94 21,704 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 5,136 Direct
Common Stock 2,014 Indirect By IRA
Common Stock 2,465 Indirect By wife & wife's IRA
Common Stock 476 Indirect By Cambridge Holdings
Footnotes
  1. Reflects a one-for five reverse stock split effected July 29, 2011 and a one-for-six reverse stock split effected June 20, 2012.
  2. Holds jointly with wife.